CompoAtlas

Oraz African Mango Plus Capsule

Oraz African Mango Plus Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Registration number
MAL18056125T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
SERI MH UMMI SDN BHD
Manufacturer
SERI MH UMMI SDN BHD
Registration period starting
2023-05-24
Published validity end
2028-05-24

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
IRVINGIA GABONENSISIRVINGIA GABONENSIS[200 mg,500 mg]Not identified
Garcinia cambogiaGarcinia cambogia[200 mg,500 mg]Not identified
Camellia sinensisCamellia sinensis[100 mg,500 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Active ingredients
IRVINGIA GABONENSIS[200 mg,500 mg],Garcinia cambogia[200 mg,500 mg],Camellia sinensis[100 mg,500 mg]
Valid until
2028-05-24
Registration date
2023-05-24
Published description
NATURAL PRODUCT
Licence holder
SERI MH UMMI SDN BHD
Producer
SERI MH UMMI SDN BHD
Published name
Oraz African Mango Plus Capsule
Published reference
201712211258T
Registration number
MAL18056125T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL18056125T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • IRVINGIA GABONENSIS
    Read the warning, when it applies and the studies cited

    AFRICAN WILD MANGO - IRVINGIA GABONENSIS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Ross 2011; Ngondi et al. 2009; Adamson et al. 1986).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Antioxidant, cholesterol, glucose.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.

    Contraindications

    Condition of application: Weight management.

    Do not use if you are pregnant.

    Known adverse reactions

    Stop use if you experience symptoms of hypoglycaemia including feelings of anxiety, dizziness, tremor, sweating, nausea or headache (Adamson et al. 1986; Ngondi et al. 2009; Oben et al. 2008a,b).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 August 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line